The novel SARS-CoV-2 (COVID-19) became a pandemic on 11 March 2020. The
epidemiological picture is constantly evolving, and on 13 May, 4,170,424 cases and …

The COVID-19 pandemic has recently been the cause of a global public health emergency.
Frequently, elderly patients experience a marked loss of muscle mass and strength during …

Background Severe clinical pictures and sequelae of COVID‐19 disease are immune
mediated and characterized by a 'cytokine storm'. Skeletal muscle has emerged as a potent …

In this review, we discuss the pathophysiologic and management aspects of acute
sarcopenia in relation to SARS-CoV-2 infection. COVID-19 is as a multi-organ infectious …

Myopathy is a disease characterized by muscle dysfunction in general and may be
associated with genetics, medication such as statins, or inflammation. In 2019, an epidemic …

Background Severe acute respiratory syndrome (SARS‐CoV‐2), caused by the Coronavirus
2019 (COVID‐19), has become a life‐threatening epidemic, affecting multiple organs …

Abstract Introduction Coronavirus disease 2019 (COVID-19) is associated to neuromuscular
symptoms in up to 10.7% of hospitalized patients. Nevertheless, the extent of muscular …

Midterm functional sequelae and implications in rehabilitation after coVid-19: a cross-sectional
study Page 1 Vol. 57 - No. 2 EuropEaN JourNal of physical aNd rEhabilitatioN MEdiciNE 199 …

The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 39
2 (SARS-CoV-2) virus, has made a staggering global impact and became one of the most 40 …

COVID-19, the clinical syndrome produced by infection with SARS-CoV-2, can result in
multisystem organ dysfunction, including respiratory failure and hypercoagulability, which …